- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04962256
ERAS in Posterior Approach of Cervical Spine Operation
October 9, 2022 updated by: Peking University Third Hospital
The Application of Enhanced Recovery After Surgery (ERAS) During the Perioperative Period of Patients With Posterior Approach of Cervical Spine Operation: a Mixed Methods Study
Enhanced recovery after surgery (ERAS) strategy has been used in the patient management of different diseases.
This study aims to evaluate the effectiveness of ERAS in the perioperative period of posterior approach of cervical spine operation among patients with CSM.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Enhanced recovery after surgery (ERAS) strategy has been used in the patient management of different diseases, but up to now, few effort has been done to evaluate the effectiveness of ERAS in patients perioperative management of cervical spine surgery.
As a interdisciplinary cooperation system, either qualitative or quantitative method alone can not completely reflect the function of ERAS.
Mixed model research (MMR) is a appropriate method to evaluate a complex system, but it has not been used in ERAS evaluation.
This study aims to evaluate the effectiveness of ERAS in the perioperative period of posterior approach of cervical spine operation among patients with CSM using MMR, including the retrospective quantitative part and prospective qualitative part.
In the retrospective part, we will collect the data of length of stay, VAS scores, mJOA scores and SF-36 scores to compare the difference between ERAS group and regular group.
In the prospective part, we will collect the data from the focus group meetings and personal interviews of patients, to verify that ERAS has the ability to improve the postoperative outcomes, while maintain an equal surgical effect.
Study Type
Observational
Enrollment (Actual)
204
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100191
- Feifei Zhou
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with posterior approach of cervical spine operation
Description
Inclusion Criteria:
- Patients should be diagnosed as CSM based on the history, symptoms, Physical signs and radiographic results.
- Patients did not respond to the 3-month conventional treatment.
- Patients were performed posterior approach of cervical spine operation.
- Patients should have complete pre- and post-operative data.
Exclusion Criteria:
- Patients with severe organic diseases.
- Patients with previous history of cervical spine surgery.
- Patients with mental or psychological abnormality.
- Patients with severe osteoporosis (T value <-2.5).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study group
Patients with degenerative CSM or OPLL undergoing C3-7 open-door laminoplasty
|
ERAS management includes 3 parts: (1) Preoperative analgesia and airway evaluation.
(2) The protection and reconstruction of the musculo-ligamentous complex during the surgery, the safe intubation, and the local infiltration anesthesia during surgery.
(3) Collar free, multimodal analgesia, airway management, and early recovery after surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Outcomes of pain
Time Frame: Preoperation
|
Visual analogue scale before after surgery, 0 to 10 points, higher means severer the pain is.
|
Preoperation
|
|
Outcomes of pain
Time Frame: 3 months after surgery.
|
Visual analogue scale 3-month after surgery, 0 to 10 points, higher means severer the pain is.
|
3 months after surgery.
|
|
Length of stay
Time Frame: Admission to discharge, an average of 3 days
|
Length of stay
|
Admission to discharge, an average of 3 days
|
|
Neurological function
Time Frame: Preoperation
|
Modified Japanese Orthopaedic Association score before surgery, -2 to 17 points, higher means better outcome.
|
Preoperation
|
|
Neurological function
Time Frame: 3 months after surgery.
|
Modified Japanese Orthopaedic Association score 3-month after surgery, -2 to 17 points, higher means better outcome.
|
3 months after surgery.
|
|
Outcomes of quality of life
Time Frame: Preoperation
|
36-Item Short Form Survey score before surgery, 0 to 100 points, higher means better outcome.
|
Preoperation
|
|
Outcomes of quality of life
Time Frame: 3 months after surgery
|
36-Item Short Form Survey score 3-month after surgery, 0 to 100 points, higher means better outcome.
|
3 months after surgery
|
|
Focus group meetings
Time Frame: Admission to discharge, an average of 3 days
|
Focus group meetings by specialists, to discuss the effect of ERAS and the what improvements can be made.
|
Admission to discharge, an average of 3 days
|
|
Personal interviews
Time Frame: At 3-month follow-up
|
Personal interviews of patients at 3-month follow-up
|
At 3-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 20, 2019
Primary Completion (ACTUAL)
March 31, 2022
Study Completion (ACTUAL)
March 31, 2022
Study Registration Dates
First Submitted
June 27, 2021
First Submitted That Met QC Criteria
July 4, 2021
First Posted (ACTUAL)
July 14, 2021
Study Record Updates
Last Update Posted (ACTUAL)
October 12, 2022
Last Update Submitted That Met QC Criteria
October 9, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M2019144
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Myelopathy
-
Medical College of WisconsinMarquette University; Froedtert Hospital; Advancing a Healthier Wisconsin EndowmentNot yet recruitingDegenerative Cervical MyelopathyUnited States
-
Valérie SchuermansRecruitingCervical Disc Disease | Cervical Fusion | Fusion of Spine | Cervical Spondylosis | Cervical Disc Herniation | Myelopathy Cervical | Cervical Disc Degeneration | Radiculopathy, Cervical | Myelopathy, Compressive | Radiculopathy, Cervical Region | Radiculopathy; in Spondylosis | Radiculopathy; in Intervertebral... and other conditionsNetherlands
-
Cambridge University Hospitals NHS Foundation TrustNational Institute for Health Research, United Kingdom; Wolfson Brain Imaging...RecruitingCervical Spondylosis With Myelopathy | Degenerative Cervical MyelopathyUnited Kingdom
-
Peking University Third HospitalCompleted
-
National Taiwan University HospitalCompletedCervical Radiculopathy | Cervical MyelopathyTaiwan
-
Unity Health TorontoUnknownCervical Radiculopathy | Cervical MyelopathyCanada
-
Shanghai Changzheng HospitalRecruitingMyelopathy CervicalChina
-
NuVasiveEnrolling by invitationCervical Radiculopathy | Cervical Disc Disease | Cervical Spine Disease | Cervical Myelopathy | Cervical Spondylosis | Cervical Disc Herniation | Cervical StenosisUnited States
-
University Medical Center GroningenActive, not recruitingCervical Radiculopathy | Cervical MyelopathyNetherlands
-
Wayne State UniversityUnknownCervical Spondylosis With Myelopathy | Cervical Spine Degenerative Disease NosUnited States
Clinical Trials on Enhanced recovery after surgery
-
Instituto Brasileiro de Controle do CancerWithdrawnEnhanced Recovery After Surgery | Gynecologic Surgical ProceduresBrazil
-
National Taiwan University HospitalEnrolling by invitationPediatric | Lung Surgery | Enhanced Recovery After Surgery, ERASTaiwan
-
The Second Hospital of Shandong UniversityRecruitingLung Cancer | Surgery | ERASChina
-
Instituto Brasileiro de Controle do CancerRecruitingGynecologic Cancer | Enhanced Recovery After SurgeryBrazil
-
Sixth Affiliated Hospital of Xinjiang Medical UniversityNot yet recruiting
-
University of ThessalyRecruitingPancreatic Cancer Resectable | Enhanced Recovery After Surgery | PancreatectomyGreece
-
Chonnam National University HospitalCompleted
-
The Second Hospital of Shandong UniversityNot yet recruiting
-
Services Hospital, LahoreCompletedEnhanced Recovery After SurgeryPakistan
-
University of Colorado, DenverRecruitingEnhanced Recovery After Surgery | Gynecologic DiseaseUnited States